JLS is an NY-based venture capital fund formed to invest in the exciting intersection of science, technology and neurology, leveraging the enormous potential of plant-based and psychedelic medicines to heal illness and enhance wellness. They focus on the development of drugs for intractable mental and physical conditions and the enabling technology and tools that can accelerate and enhance the delivery of those therapies.
| Website | https://jls.fund/ |
| Employees | 8 (2 on RocketReach) |
| Founded | 2019 |
| Industry | Venture Capital and Private Equity Principals |
| Keywords | Venture Capital, Investment Fund, Plant Based Medicine, Psychedelic Medicine, Neurology, Biotechnology, Science, Technology, Healthcare, Wellness, Therapeutics, Medicine, Health, Alternative Medicine, Natural Medicine, Clinical Trials, Drug Development, Pharmaceutical, Research And Development |
| Competitors | BlackRock, J.P. Morgan, State Street Global Advisors, SoftBank Investment Advisers, Advent International, Bridgewater Associates, Millennium, Fidelity Investments, Oaktree Capital Management, L.P., Viking Global Investors +35 more (view full list) |
Looking for a particular JLS Fund employee's phone or email?
Simeon Schnapper is the Managing Partner of JLS Fund.
2 people are employed at JLS Fund.